Yes, absolutely continue both physical therapy and mental health therapy—they are essential components of managing your anti-RNP-positive inflammatory myositis and preventing demoralization.
Physical therapy is critical for maintaining and regaining muscle strength in inflammatory myositis, and mental health support helps you cope with the chronic nature of this condition without becoming overwhelmed. 1
Why Physical Therapy Is Essential
Your anti-RNP-positive myositis typically causes progressive proximal and distal weakness that affects 80% of patients over time 1. Physical therapy serves multiple crucial functions:
- Prevents muscle atrophy and contractures during periods of active disease or immunosuppressive treatment
- Rebuilds strength gradually as inflammation is controlled with medical therapy
- Maintains functional independence in daily activities
- Monitors for disease progression through objective strength assessments
The evidence shows that patients with anti-RNP myositis generally respond well to treatment, with many achieving remission and discontinuing corticosteroids 2. Physical therapy accelerates this recovery and prevents deconditioning during the treatment phase.
Why Mental Health Therapy Matters
The psychological burden of chronic inflammatory myositis is substantial and well-recognized in rheumatic diseases 3. Mental health therapy addresses:
- Fatigue management: Structured psychoeducational interventions help you understand and cope with the profound fatigue that accompanies inflammatory myositis 3
- Coping strategies: Learning to manage the uncertainty of disease flares and treatment responses
- Preventing demoralization: Chronic muscle weakness and functional limitations can lead to depression and anxiety
- Maintaining treatment adherence: Staying motivated through long-term immunosuppressive therapy
Access to psychoeducational interventions should be needs-based and not restricted—you may benefit from these interventions at different points in your disease trajectory 3.
Your Specific Clinical Context
Your case has several features that make continued therapy particularly important:
Mild CK elevation with progressive weakness: This pattern suggests ongoing disease activity that requires both medical management and rehabilitation 1
Anti-RNP positivity in a young Black male: You fit the typical demographic (younger age, Black ethnicity) for this myositis subtype, which generally has a favorable prognosis with appropriate treatment 1
Normal organ function: Your preserved cardiac, renal, and liver function is reassuring and suggests you can tolerate the physical demands of rehabilitation
G6PD deficiency: This doesn't contraindicate physical therapy or mental health interventions, though it does limit certain medication options (avoid NSAIDs like phenazopyridine if needed for pain management) 4
Practical Approach
Continue both therapies with this framework:
- Physical therapy: Focus on gradual strength training tailored to your current weakness pattern (both proximal and distal). Monitor for post-exertional fatigue or weakness that might indicate overexertion
- Mental health therapy: Engage in structured psychoeducational interventions that address fatigue, coping with chronic illness, and maintaining motivation through treatment
- Coordinate with rheumatology: Your therapies should align with your immunosuppressive treatment plan. As inflammation decreases with medical therapy, your physical function should improve 2
Common Pitfall to Avoid
Do not interpret lack of immediate improvement as treatment failure. Anti-RNP myositis often requires months of immunosuppressive therapy before significant strength gains occur. Physical therapy during this period prevents deconditioning and positions you for better recovery once inflammation is controlled 2. Similarly, mental health benefits may accumulate gradually as you develop better coping strategies.
The combination of appropriate medical therapy, physical rehabilitation, and psychological support gives you the best chance for functional recovery and quality of life in anti-RNP-positive myositis.